culturebiosciences.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $101.6MM
Culture Biosciences develops automated bioreactors and a cloud-based solution for analyzing and visualizing data.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
10/14/2021 | Series B | $80MM | $xx.xx | $295.51MM | Northpond Ventures, Synthesis Capital, Cultivian Sandbox Ventures, The Production Board, Craft Ventures, E14 Fund, Box Group, Verily Life Sciences, Section 32 | |
Price per Share
$xx.xx
Shares Outstanding
10,947,806
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Northpond Ventures, Synthesis Capital, Cultivian Sandbox Ventures, The Production Board, Craft Ventures, E14 Fund, Box Group, Verily Life Sciences, Section 32
|
||||||
03/04/2020 | Series A-1 | $15.12MM | $xx.xx | $42.06MM | Cultivian Sandbox, The Production Board, Verily Life Sciences, Section 32, YCombinator, E14 Fund | |
Price per Share
$xx.xx
Shares Outstanding
9,258,333
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Cultivian Sandbox, The Production Board, Verily Life Sciences, Section 32, YCombinator, E14 Fund
|
||||||
03/01/2019 | Series A-6 | $1.61MM | $xx.xx | $18.39MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
988,847
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
03/01/2019 | Series A-5 | $4.11MM | $xx.xx | $18.39MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
3,121,439
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
03/01/2019 | Series A-4 | $150,000 | $xx.xx | $18.39MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
364,077
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
03/01/2019 | Series A-3 | $300,000 | $xx.xx | $18.39MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
809,061
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|
||||||
03/01/2019 | Series A-2 | $300,000 | $xx.xx | $18.39MM | Undisclosed Investors | |
Price per Share
$xx.xx
Shares Outstanding
910,194
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Undisclosed Investors
|